We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov Menu

Bone Status and Insulin Resistance in Hirsutism

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: September 2, 2005
Last Update Posted: June 24, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Odense University Hospital

The purpose of this study is to investigate how the bones of hirsute women are different from bones of healthy women. The change in hormone content in the blood will also be investigated. The study can be used to evaluate whether it will be relevant to bone scan all newly referred hirsute women.

Hirsute women are often over-weight and often have an increased amount of the male sex hormone in their blood. Their blood tests often show changes reminding of the ones seen in diabetic patients.

All hirsute women referred to the department will undergo an investigation revealing the reason for the increased hair growth. The investigation includes clinical investigation (height, weight and degree of hair growth), blood tests (for hormone status and bone status analysis) and bone scanning of the abdomen (body composition).

The trial includes a group of 50 strongly hairy women and a control group of 50 healthy women with normal hair growth. They are matched by body weight, since weight has great importance for the bone mineral content and thereby for osteoporosis in the long run.


Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Body Composition, Insulin Concentration, Androgens and Bone Status in Women Referred With Hirsutism

Resource links provided by NLM:

Further study details as provided by Odense University Hospital:

Enrollment: 50
Study Start Date: January 2002
Study Completion Date: January 2007
Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   20 Years to 46 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Study Population
hirsute patients vs. controls

Inclusion Criteria:

Hirsute subjects:

  • Belonging to group 1 or 2.
  • Age: 20-46
  • Hirsute score: >7
  • Written informed consent

Control group:

  • Age: 20-46
  • Hirsute score: 0 (without razing)
  • Regular menses
  • Written informed consent

Exclusion Criteria:

  • Previous cosmetic treatment for hirsutism.
  • Use of contraceptive pill (within the past 6 months)
  • Systemic steroid treatment > 6 weeks (ever)
  • Age above 46 years/post menopause (increased FSH)
  • Recognized diabetes mellitus or other endocrine disease
  • Eating disorder
  • Serious, treatment demanding disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00143052

Diabetes Research Center
Odense, Funen, Denmark, 5000
Sponsors and Collaborators
Odense University Hospital
Principal Investigator: Dorte Glintborg, MD Odense University Hospital
  More Information

Responsible Party: Odense University Hospital
ClinicalTrials.gov Identifier: NCT00143052     History of Changes
Other Study ID Numbers: 003
First Submitted: September 1, 2005
First Posted: September 2, 2005
Last Update Posted: June 24, 2008
Last Verified: June 2008

Keywords provided by Odense University Hospital:
Bone status

Additional relevant MeSH terms:
Hair Diseases
Skin Diseases
Signs and Symptoms
Hypoglycemic Agents
Physiological Effects of Drugs
Hormones, Hormone Substitutes, and Hormone Antagonists